COMPUGEN | 4,261 Euro | -0,033 -0,77 % | |
| WKN: 553001 ISIN: IL0010852080 Ticker-Symbol: CW9 | Berlin | 17.05.13 | 08:07 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 08.05. | Compugen is Among the Companies in the Life Sciences Tools & Services Industry With the Lowest Revenue Per Employee | - | SmarTrend | |
| 26.04. | Compugen's CEO Discusses Q1 2013 Results - Earnings Call Transcript | 1 | Seeking Alpha | |
| 10.04. | Buyers Accumulate Shares of Compugen, Up 4.2% | 1 | SmarTrend | |
| 01.04. | Relatively High Current Ratio Detected in Shares of Compugen in the Life Sciences Tools & Services Industry | 1 | SmarTrend | |
| 13.03. | Shares of Compugen Under Pressure, Down 10.7% | 1 | SmarTrend | |
| 26.02. | Compugen Awarded HP Partner in Excellence Award | 60 | Marketwired | |
| TORONTO, ONTARIO -- (Marketwire) -- 02/26/13 -- Compugen Inc. today announced that it has been recognized with an HP Partner in Excellence Award for Canada Philanthropy at the 2013 HP Global Partner... Mehr lesen zu: Compugen Awarded HP Partner in Excellence Award | ||||
| 20.02. | Compugen's CEO Discusses Q4 2012 Results - Earnings Call Transcript | - | Seeking Alpha | |
| 11.01. | Stock Investors Sell Off Shares of Compugen, Down 4.8% | 1 | SmarTrend | |
| 10.01. | Compugen Shares Up 54.5% Since SmarTrend's Buy Recommendation | 1 | SmarTrend | |
| 19.12. | 42.1% Return Seen to Date on SmarTrend Compugen Call | - | SmarTrend | |
| 13.12. | Shares of Compugen Receive a Boost, Up 11.0% | - | SmarTrend | |
| 12.12. | Compugen Shares Up 36.0% Since SmarTrend's Buy Recommendation | 1 | SmarTrend | |
| 20.11. | Compugen a Double Winner in the 2012 Microsoft Partner Network IMPACT Awards / Microsoft Canada Inc recognizes achievements of leading Canadian technology partners | 104 | Marketwired | |
| TORONTO, ONTARIO -- (Marketwire) -- 11/20/12 -- Compugen announced today that it has been selected as the winner in the Volume Licensing Partner of the Year and the Community Leadership Partner of... Mehr lesen zu: Compugen a Double Winner in the 2012 Microsoft Partner Network IMPACT Awards / Microsoft Canada Inc recognizes achievements of leading Canadian technology partners | ||||
| 14.11. | Compugen to Present at Jefferies 2012 Global Healthcare Conference | 82 | Business Wire | |
| Compugen Ltd. (NASDAQ: CGEN) today announced that its President and
Chief Executive Officer, Dr. Anat Cohen-Dayag, will be presenting at the
Jefferies 2012 Global Healthcare... Mehr lesen zu: Compugen to Present at Jefferies 2012 Global Healthcare Conference | ||||
| 18.09. | Compugen Wins Gold and Silver at Channel Elite Awards / Datacentre Rebuild wins Gold in Enterprise Category; Desktop Virtualization Solution wins Silver in Mid-Market Category | 54 | Marketwired | |
| TORONTO, ONTARIO -- (Marketwire) -- 09/18/12 -- Compugen Inc., Canada's largest IT solutions and services provider, is pleased to announce major peer recognition at 2012 Channel Elite Awards ceremony... Mehr lesen zu: Compugen Wins Gold and Silver at Channel Elite Awards / Datacentre Rebuild wins Gold in Enterprise Category; Desktop Virtualization Solution wins Silver in Mid-Market Category | ||||
| 10.09. | Compugen Drug Candidate Demonstrates Attenuation of Autoimmunity and Reestablishment of Immune Balance | 46 | Business Wire | |
| Suggested mode of action for CGEN-15001 directly impacts key
pathogenic aspects of autoimmune disease
Results from pre-clinical studies for CGEN-15001 immune... Mehr lesen zu: Compugen Drug Candidate Demonstrates Attenuation of Autoimmunity and Reestablishment of Immune Balance | ||||
| 24.07. | Another Compugen Milestone: One Millionth Service Call Completed | 24 | Marketwired | |
| TORONTO, ONTARIO -- (Marketwire) -- 07/24/12 -- Canadian IT solutions provider Compugen Inc. today announced the completion of its one millionth service call. Service calls involve on-site visits by... Mehr lesen zu: Another Compugen Milestone: One Millionth Service Call Completed | ||||
| 25.06. | Merck Serono, Compugen To Establish Neviah Genomics | 111 | AFX News | |
| BERLIN (dpa-AFX) - Merck Serono, a division of Merck, Darmstadt, Germany,
and Compugen Ltd. (CGEN) announced the joint establishment of Neviah Genomics, a
novel start-up company focused... Mehr lesen zu: Merck Serono, Compugen To Establish Neviah Genomics | ||||
| 25.06. | Compugen und Merck Serono Ventures gründen neues Biomarker-Unternehmen Neviah Genomics | 168 | news aktuell-CH | |
| Genf Und Tel Aviv, Israel (ots/PRNewswire) - - Neviah Genomic soll sich auf die Entdeckung und Entwicklung neuartiger Biomarker für Arzneimitteltoxizität konzentrieren - Compugen... Mehr lesen zu: Compugen und Merck Serono Ventures gründen neues Biomarker-Unternehmen Neviah Genomics | ||||
| 25.06. | Compugen and Merck Serono Ventures to Jointly Establish New Biomarker Company Neviah Genomics Ltd. | 50 | Business Wire | |
| Neviah Genomic Ltd. to focus on the discovery and development of
novel biomarkers for drug toxicity
Compugen to utilize its predictive discovery technologies... Mehr lesen zu: Compugen and Merck Serono Ventures to Jointly Establish New Biomarker Company Neviah Genomics Ltd. | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| EVOTEC | 2,818 | +0,07 % | Evotec: Kurs der Aktie hat weiteres Potenzial |
| SANGAMO BIOSCIENCES | 6,583 | +1,28 % | Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic, SB-728-T |
| LEXICON PHARMACEUTICALS | 1,662 | -0,42 % | Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results |
| ANTISOMA | 0,017 | -10,53 % | Antisoma PLC: TR1 Notification of major interest in shares |
| HELIX BIOPHARMA | 0,637 | +6,17 % | Helix BioPharma Corp. Announces L-DOS47 Scientific Poster to Be Presented at American Association for Cancer Research Annual Meeting in Washington, DC |
